Article citationsMore>>

Furler, M.D., Rolnick, M.S., et al. (2002) Cost impact of switching histamine(2)-receptor antagonists to nonprescription status. The Annals of Pharmacotherapy, 36, 1135-1141. http://dx.doi.org/10.1345/aph.1A231

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top